Diversification of Escherichia coli expressing an SHV-type extended- spectrum β-lactamase (ESBL) during a hospital outbreak: Emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 393-396

  Pałucha, Andrzej ^a   Mikiewicz, Barbara ^b   Gniadkowski, Marek ^a  

^a Sera & Vaccines Central Research Laboratory Warszawa   (Poland)

^b Hlth Care Ctr Praga Po noc   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; IMIPENEM; PIPERACILLIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; GENETIC ANALYSIS; HOSPITAL INFECTION; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; NEWBORN INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0345040154     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.393     Document Type: Article

References (19)

1. Bauernfeind, A., J. M. Casellas, M. Goldberg, M. Holley, R. Jungwirth, P. Mangold, T. Röhnisch, S. Schweighart, and R. Wilhelm. 1992. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20:158-163.
2. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
3. Chen, S.-T., and R. C. Clowes. 1984. Two improved promoter sequences for the β-lactamase expression arising from a single base-pair substitution. Nucleic Acids Res. 12:3219-3234.
4. Chen, S.-T., and R. C. Clowes. 1987. Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. J. Bacteriol. 169:913-916.
5. French, G. L., K. P. Shannon, and N. Simmons. 1996. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J. Clin. Microbiol. 34:358-363.
6. Gniadkowski, M., I. Schneider, R. Jungwirth, W. Hryniewicz, and A. Bauernfeind. 1998. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42:514-520.
7. Gniadkowski, M., I. Schneider, A. Pałucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw. Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.
8. Goussard, S., W. Sougakoff, C. Mabilat, A. Bauernfeind, and P. Courvalin. 1991. An ISI-like element is responsible for high-level synthesis of extended-spectrum β-lactamase TEM-6 in Enterobacteriaceae. J. Gen. Microbiol. 137: 2681-2687.
9. th International Congress of Bacteriology and Applied Microbiology Division, International Union of Microbiological Societies, Jerusalem. Israel, 18 to 23 September 1996.
10. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
11. Mabilat, C., S. Goussard, W. Sougakoff, R. C. Spencer, and P. Courvalin. 1990. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 23:1-8.
12. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focussing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
13. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Nuesch-Inderbinen, M. T., F. H. Kayser, and H. Hächler. 1997. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41:943-949.
15. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shingler. 1972. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
16. Prinarakis, E. E., E. Tzelepi, M. Gazouli, A. F. Mentis, and L. S. Tzouvelekis. 1996. Characterization of a novel SHV β-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol. Lett. 139:229-234.
17. Reguera, J. A., F. Baquero, J. C. Perez-Diaz, and J. L. Martinez. 1988. Synergistic effect of dosage and bacterial inoculum in TEM-1 mediated antibiotic resistance. Eur. J. Clin. Microbiol. Infect. Dis. 7:778-779.
18. Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
19. van Belkum, A., J. Kluytmans, W. van Leeuwen, R. Bax, W. Quint, E. Peters, A. Fluit, C. Vandenbroucke-Grauls, A. van den Brule, H. Koeleman, W. Melchers, J. Meis, A. Elaichouni, M. Vaneechoutte, F. Moonens, N. Maes, M. Struelens, F. Tenover, and H. Verbrugh. 1995. Multicenter evaluation of arbitrary primed PCR for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 33:1537-1547.